Peptide pain evidence index
Bottom line: “Peptide” is a molecule category, not a guarantee. The evidence runs from an FDA-approved pain medicine to products with no established human benefit.
Looking for a direct comparison? Read what “best peptide for pain” means when the evidence is ranked by pain type.
| Intervention | What was studied | Human evidence | U.S. status |
|---|---|---|---|
| Ziconotide | Severe chronic pain | Controlled trials; established specialist use | FDA-approved for a narrow indication |
| Semaglutide | Knee osteoarthritis pain in people with obesity | One large, high-quality randomized trial | Approved for other indications, not specifically arthritis pain |
| TPX-100 | Knee osteoarthritis function and structure | Randomized paired-knee signal; 270-person Phase 2 study active | Investigational |
| Collagen peptides | Knee osteoarthritis symptoms | Multiple randomized trials; results favorable but heterogeneous | Dietary supplements, not FDA-approved pain drugs |
| Cibinetide / ARA-290 | Small-fiber neuropathy | Small early trials; clinical benefit not established | Investigational; not FDA-approved |
| BPC-157 | Pain and injury recovery | Limited early evidence; 120-person Phase 2 hamstring trial recruiting | No FDA-approved drug; advisory panel recommended 503A compounding-list inclusion in July 2026 |
| TB-500 | Healing and tissue-repair claims | No established human clinical evidence | Not FDA-approved |
How to read the index
Established means a treatment has controlled human evidence and a defined medical use. Promising means biological, real-world, or early human signals exist but important questions remain. Not established means the size and reliability of the human benefit have not yet been measured well.
Approval is not the same as usefulness for every patient. Likewise, lack of approval does not prove a molecule can never work. It means the necessary case has not been made.
Discovery research to watch
Explore the cAmbly research feature, added September 10, 2026. Discovery-stage coverage sits alongside this clinical evidence table; it is not a ranking of treatment options.
Download the underlying data
Download as CSV or view the JSON dataset. Each record includes scope, status, source, review date, and the central evidence limitation.
Clinical table last reviewed August 23, 2026. Discovery link added September 10, 2026. To report a correction or new study, contact the editorial desk.